![Development of Potent Mcl‑1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen](https://www.reactionbiology.com/wp-content/uploads/2024/02/Screenshot_3-1055x675.png)
![Development of Potent Mcl‑1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen](https://www.reactionbiology.com/wp-content/uploads/2024/02/Screenshot_3-1055x675.png)
![PROxAb Shuttle: A non-covalent plug-and-play platform for the rapid generation of tumor-targeting antibody-PROTAC conjugates](https://www.reactionbiology.com/wp-content/uploads/2024/02/Screenshot_2-886x675.png)
PROxAb Shuttle: A non-covalent plug-and-play platform for the rapid generation of tumor-targeting antibody-PROTAC conjugates
![Anilino-monoindolylmaleimides as potent and selective JAK3 inhibitors. Bioorganic & Medicinal Chemistry Letters, 2014](https://www.reactionbiology.com/wp-content/uploads/2023/11/2014_JAK3-inhibitor-discovery_Bioorg-Med-Chem_thumb.png)
Anilino-monoindolylmaleimides as potent and selective JAK3 inhibitors. Bioorganic & Medicinal Chemistry Letters, 2014
![Thiophene-pyrazolourea derivatives as potent, orally bioavailable, and isoform-selective jnk3 inhibitors. ACS Medicinal Chemistry Letters, 2021](https://www.reactionbiology.com/wp-content/uploads/2023/11/JNK3_Publication_thumbnail.png)
Thiophene-pyrazolourea derivatives as potent, orally bioavailable, and isoform-selective jnk3 inhibitors. ACS Medicinal Chemistry Letters, 2021
![Kinase Inhibitor Profiling Reveals Unexpected Opportunities to Inhibit Disease-Associated Mutant Kinases. Cell Reports, 2016](https://www.reactionbiology.com/wp-content/uploads/2023/11/2016_small-panel_Cell_thumb.png)